Answer
Attia dipyridamole modified-release capsules are indicated for secondary prevention of ischaemic stroke and transient ischaemic attacks, alone or with aspirin, and prevention of thromboembolism associated with prosthetic heart valves as an adjunct to oral anticoagulation.
Sources for this answer
- Attia 200 mg Modified-Release Capsules, HardDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked